Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Boston Scientific’s Angelo Auricchio on what’s next for heart health
Discover what’s on the horizon for cardiac care and remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific.
Read more
Boston Scientific’s Angelo Auricchio on what’s next for heart health
Discover what’s on the horizon for cardiac care and remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific.
The HBA’s Mary Stutts on tackling bias for better women’s health
Mary Stutts, CEO, HBA, unpacks the key findings of a report exposing critical gaps in doctors’ understanding of women’s health.
Does interactivity boost memory, recall and retention?
Explore the science behind memory, recall and retention, and uncover why interactive content could be the future in this podcast.
J&J’s Martin Price on World Cancer Day 2025 – Part 2
Uncover more of Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson’s thoughts on the oncology space
J&J’s Martin Price on World Cancer Day 2025 – Part 1
A World Cancer Day edition of the podcast, with Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, J&J.
Lundbeck’s Charl van Zyl on a new era in neurology
The team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders.
The 2025 pharma forecast
Curious to know could happen in the industry in 2025? Join us as we talk to three guests about their top predictions for the year ahead.
Pharma review of the year 2024
Look back at the key moments from the past year in pharma with three of our former guests, as they highlight key trends, challenges and more.
Loading posts...
1
2
3
…
24
Next »